BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37864711)

  • 21. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
    Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
    Huang RY; Wen PY
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria.
    Sharma M; Juthani RG; Vogelbaum MA
    Chin Clin Oncol; 2017 Aug; 6(4):37. PubMed ID: 28841799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
    Nayak L; DeAngelis LM; Brandes AA; Peereboom DM; Galanis E; Lin NU; Soffietti R; Macdonald DR; Chamberlain M; Perry J; Jaeckle K; Mehta M; Stupp R; Muzikansky A; Pentsova E; Cloughesy T; Iwamoto FM; Tonn JC; Vogelbaum MA; Wen PY; van den Bent MJ; Reardon DA
    Neuro Oncol; 2017 May; 19(5):625-635. PubMed ID: 28453751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2008 annual meeting of the International Society for Pediatric Neurosurgery: highlights of the oncology session.
    Bouffet E
    Expert Rev Neurother; 2009 Jan; 9(1):43-5. PubMed ID: 19102667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
    Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
    Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document.
    Rudà R; Angileri FF; Ius T; Silvani A; Sarubbo S; Solari A; Castellano A; Falini A; Pollo B; Del Basso De Caro M; Papagno C; Minniti G; De Paula U; Navarria P; Nicolato A; Salmaggi A; Pace A; Fabi A; Caffo M; Lombardi G; Carapella CM; Spena G; Iacoangeli M; Fontanella M; Germanò AF; Olivi A; Bello L; Esposito V; Skrap M; Soffietti R;
    J Neurosurg Sci; 2020 Aug; 64(4):313-334. PubMed ID: 32347684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment on "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee".
    Harreld JH
    Neuro Oncol; 2018 Jan; 20(1):143-144. PubMed ID: 29329452
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to Harreld re: "Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee".
    Warren KE; Vezina G; Poussaint TY; Warmuth-Metz M; Packer RJ; Kieran MW
    Neuro Oncol; 2018 Jan; 20(1):144-145. PubMed ID: 29329453
    [No Abstract]   [Full Text] [Related]  

  • 35. Evolving management of low grade glioma: No consensus amongst treating clinicians.
    Field KM; Rosenthal MA; Khasraw M; Sawkins K; Nowak AK
    J Clin Neurosci; 2016 Jan; 23():81-87. PubMed ID: 26601811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
    Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K
    Nat Med; 2024 Jan; 30(1):207-217. PubMed ID: 37978284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Prevalence of Developmental Venous Anomaly in Diffuse Intrinsic Pontine Gliomas: A Pediatric Control Study.
    Roux A; Boddaert N; Grill J; Castel D; Zanello M; Zah-Bi G; Chrétien F; Lefevre E; Ros VD; Zerah M; Puget S; Pallud J; Varlet P
    Neurosurgery; 2020 Apr; 86(4):517-523. PubMed ID: 31342064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine.
    Blumenthal DT; Artzi M; Liberman G; Bokstein F; Aizenstein O; Ben Bashat D
    AJNR Am J Neuroradiol; 2017 May; 38(5):908-914. PubMed ID: 28385884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood brain tumors: current management, biological insights, and future directions.
    Pollack IF; Agnihotri S; Broniscer A
    J Neurosurg Pediatr; 2019 Mar; 23(3):261-273. PubMed ID: 30835699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric glial tumors.
    Cohen KJ; Broniscer A; Glod J
    Curr Treat Options Oncol; 2001 Dec; 2(6):529-36. PubMed ID: 12057098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.